Show simple item record

Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel

dc.contributor.authorKirkby, NSen_US
dc.contributor.authorLeadbeater, PDMen_US
dc.contributor.authorChan, MVen_US
dc.contributor.authorNylander, Sen_US
dc.contributor.authorMitchell, JAen_US
dc.contributor.authorWarner, TDen_US
dc.date.accessioned2018-09-25T10:19:55Z
dc.date.issued2011-10en_US
dc.date.submitted2018-01-17T13:11:26.761Z
dc.identifier.issn1538-7933en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/45164
dc.format.extent2103 - 2105en_US
dc.language.isoenen_US
dc.relation.ispartofJ THROMB HAEMOSTen_US
dc.subjectPLATELET-AGGREGATIONen_US
dc.subjectTHERAPYen_US
dc.subjectCLOPIDOGRELen_US
dc.titleAntiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrelen_US
dc.typeArticle
dc.rights.holder© 2011 International Society on Thrombosis and Haemostasis
dc.identifier.doi10.1111/j.1538-7836.2011.04453.xen_US
pubs.issue10en_US
pubs.notesNot knownen_US
pubs.volume9en_US


Files in this item

Thumbnail
Name:
Chan_Antiplatelet effects of ...
Size:
155.7Kb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record